Compound ID | 11

Update compound information

Anuran Trypsin Inhibitory Peptide SLF1

Class: Experimental

Spectrum of activity: Gram-positive
Details of activity: S. aureus skin infections
Institute where first reported: Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
Year first mentioned: 2015
Highest developmental phase: Preclinical
Development status: Active
External links:
Citations:
  • http://aac.asm.org/content/59/4/2113.full
  • https://journals.asm.org/doi/full/10.1128/aac.04324-14

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.